Dysregulation of how platelets store, sequester and release specific proteins seems to be implicated in many disease states, including cancer. Dual-color immunofluorescence stimulated emission depletion (STED) microscopy with 40 nm resolution was used to map pro-angiogenic VEGF, anti-angiogenic PF-4 and fibrinogen in more than 300 individual platelets. This imaging technique, offering distinct resolving advantages for protein localization studies in platelets, reveals that these proteins are stored in a segmented, zonal manner within regional clusters, significantly smaller than the size of an -granule. No co-localization between the different proteins could be observed. Moreover, upon platelet activation by thrombin or ADP, the proteins were found to undergo significant spatial rearrangements, including alterations in the size and number of the protein clusters, which were specific for a certain protein and the type of activation induced. Following these observations, we devised a simple assignment procedure, showing that the three distinct states of platelets (non-, ADP-and thrombin-activated) can be identified based on the average size, number and peripheral localization profiles of the regional protein clusters within the platelets. This suggests that high-resolution spatial mapping in platelets of specific proteins is a useful procedure to detect and characterize deviations in the selective storage, release and uptake of these proteins in the platelets. Since these deviations seem to be specific for, and may even underlie certain patophysiological states including cancer, these findings may have interesting diagnostic and even therapeutic implications.
Abstract:
Dysregulation of how platelets store, sequester and release specific proteins seems to be implicated in many disease states, including cancer. Dual-color immunofluorescence stimulated emission depletion (STED) microscopy with 40 nm resolution was used to map pro-angiogenic VEGF, anti-angiogenic PF-4 and fibrinogen in more than 300 individual platelets. This imaging technique, offering distinct resolving advantages for protein localization studies in platelets, reveals that these proteins are stored in a segmented, zonal manner within regional clusters, significantly smaller than the size of an -granule. No co-localization between the different proteins could be observed. Moreover, upon platelet activation by thrombin or ADP, the proteins were found to undergo significant spatial rearrangements, including alterations in the size and number of the protein clusters, which were specific for a certain protein and the type of activation induced. Following these observations, we devised a simple assignment procedure, showing that the three distinct states of platelets (non-, ADP-and thrombin-activated) can be identified based on the average size, number and peripheral localization profiles of the regional protein clusters within the platelets. This suggests that high-resolution spatial mapping in platelets of specific proteins is a useful procedure to detect and characterize deviations in the selective storage, release and uptake of these proteins in the platelets. Since these deviations seem to be specific for, and may even underlie certain patophysiological states including cancer, these findings may have interesting diagnostic and even therapeutic implications.
Introduction
It is becoming increasingly clear that there is a role for platelets beyond their participation in hemostasis. Platelet dysfunction can lead not only to bleeding disorders and thrombosis, but can also be associated with artherosclerosis, immunological disorders, as well as with cancer [1] . Cancer patients often present with changed coagulation parameters, increased platelet turnover, and various forms of thrombosis, whose severity correlate with the progress of the metastatic stage. The detailed mechanisms behind these observations have remained unclear, but recent findings have stimulated a renewed focus onto the involvement of platelets in tumor development and growth (for reviews, see [2] [3] [4] ). Even the growth of very small tumors (< 1mm 3 ) is dependent on neovasculature development [5] . Studies on mice bearing human malignant tumour xenografts have shown that circulating platelets can specifically sequester angiogenesis regulatory proteins strongly correlated to micrometastasis, even in the presence of very small tumours (< 1mm 3 ) and when no significant change in the plasma content of the same angiogenesis regulatory proteins can be observed [6] . Similar alterations, representing a "metastatic/malignant platelet phenotype" has also been seen in patients with different, newly diagnosed metastatic diseases, displaying both increased and decreased platelet contents of specific, in particular angiogenesis regulating proteins [7] . This suggests that tumour-associated alterations in the protein content in platelets can be valuable biomarkers for early cancer progression.
Apart from mere up-and down-regulation of the protein content in platelets, further information with possible diagnostic and therapeutic implications may be obtained by studying the underlying regulation itself, i.e. changes in the selective harboring and subsequent release of platelet protein contents upon different activations. To date, more than 300 different molecules have been detected in platelet releasates [8] .
Presumably, the regulation of secretion and uptake of proteins in the platelets is central for their multifaceted role and dys-regulation of this activity may to a large part underlie the pathophysiological states associated with aberrant platelet activation and aggregation. Further understanding of this regulation is a key step to develop efficient therapies against cancer metastasis, and other unwanted effects associated to platelets, such as their pro-inflammatory role in atherosclerosis.
In platelets, -granules act as the major protein storage and secretory organelle [1c;2] .
-granules may also contain proteins with apparently conflicting functions, including proangiogenic and antiangiogenic factors, and it remains an open question how release of such opposing factors can be physiologically balanced. Recent findings suggest that pro-and anti-angiogenic proteins are organized in separate -granules in the platelets, which upon stimulation may be differentially released [5] . In contrast, other recent immunofluorescence co-localization data report little, if any, co-clustering of 15 angiogenesis-related proteins, instead indicating a stochastic distribution of the proteins into different -granules, and that differential protein release is rather due to zonal segregation of proteins within individual granules [9] . This is supported by electron tomography data, providing evidence for morphological and molecular heterogeneties in the -granule population, and high spatial segregation of cargo within individual -granules [10] .
To date, practically all imaging studies on storage and release of proteins in platelets have been performed by either immunofluorescence, typically using confocal laser scanning microscopy (CLSM), or by electron microscopy (EM). Fluorescence readouts offer high sensitivity, specificity and throughput, and the labeling and readout can be done with minor perturbations on the cells. However, the dimensions of a platelet is 2-4 m, a typical -granule 200-500nm [5;10] , and any structures within the -granule are of even smaller dimensions. Consequently, the resolution of CLSM (about 250nm), and even of the more elaborate structured illumination microscopy (at best 100nm [11] , makes it difficult to evaluate the distribution of proteins within the platelets, and in particular any co-localization of proteins or zonal confinement of proteins within individual -granules. This lack of adequate resolution most likely underlies the controversy in how specific proteins are stored and released from platelets [12] .
In contrast, EM can provide the necessary resolution. However, prior to imaging by EM, the samples must undergo repetitive fixation, dehydration, embedding, ultrathin sectioning and several rounds of staining, an extensive preparation protocol with low throughput that may also distort the samples. Typically, the sections examined are not sufficiently thick to encompass entire organelles, and hence morphologic records are based on inferences from organelle fragments. Moreover, the degree of immunogold-labeling is lower than for immunofluorescence. Due to steric hindrance [13] , or reduced probe penetration into the samples [14] , immunogold-labeling using gold particles with diameters of 5-15nm (typical range used) display a size-dependent reduction in the labelling efficiency by as much as an order of magnitude. This further reduces the completeness of view of the protein content within the individual organelles.
To overcome the limitations of CLSM and EM, respectively, we introduce fluorescence-based nanoscopy, based on stimulated emission depletion (STED) microscopy [15] , and with dual-color readout capability [16] to study protein storage, co-localisation and secretion in human platelets. By immunofluorescence STED microscopy we can encompass both a sufficient spatial resolution and degree of labeling, avoid extensive and perturbing sample preparations, make our observations on intact organelles and platelets, and on sufficient numbers of platelets to take platelet-to-platelet variations into account. In this work, we utilized a home-built STED instrument with a resolution of 40 nm to study how the pro-angiogenic protein VEGF (vascular endothelial growth factor), the anti-angiogenic protein PF-4 (platelet factor 4) and fibrinogen (Fg) are distributed within human platelets at rest, and upon activation by thrombin and by ADP. Our studies provide specific, high-resolution information at the subcellular level on the spatial distribution of the proteins, and on the size and number of the regional clusters in which the proteins accumulate.
Analyzing this information, we find that we can resolve features in the distributions that are specific for the different proteins and the type of activation induced. This suggests that protein distribution patterns and redistribution of proteins within
Results and discussion

STED versus confocal images of platelets
VEGF, PF-4 and Fg were separately mapped in individual platelets together with actin using confocal and STED imaging. Deconvolution of the STED images (STED+) was performed to reduce noise and increase contrast allowing for easier analysis [17] . As illustrated by the VEGF proteins imaged in figure 1A , the spatial distribution of the labeled proteins can not be resolved in the confocal images, and the localization, size and numbers of the protein clusters are not quantifiable. In contrast, the STED images can reveal clear and separate intensity profiles, providing detailed information about cluster numbers and sizes, and where the proteins are stored in the platelets. Also the images of the actin cytoskeleton benefit from the higher resolution, and give more details to the structures and shapes of the platelets. For the STED images of the VEGF distribution in the platelets (figure 1A), we note that the sizes of the VEGF clusters are significantly smaller than the expected size of the -granules (200-500nm). The same observation was also made in the STED images of platelets where PF-4 or Fg was labeled ( figure 1B ). This supports recent reports [9] [10] indicating that proteins are stored in the -granules in a segregated, zonal manner, rather than within the full reservoir volume of the -granule. Figure 2 , A2,B2,C2). Upon ADP activation actin depolymerizes into its monomer form [18] . This disallows phalloidin staining, and results in dotty intensity structures in the images of the ADP treated platelets ( Figure 2 , A3,B3,C3). 
Protein distribution patterns of VEGF, PF-4 and
Analysis of protein cluster sizes and numbers
To quantify the observed protein distribution patterns and the specific changes in protein storage coupled to platelet activation and to take platelet-to-platelet variations (Figure 2, C1, C3 ). This indicates that endogenous proteins have been transported to the edge of the cell, but the strongly peripheral distribution can also be due to external Fg binding to the activated platelets [20] .
Despite a large platelet-to-platelet variability in the 
Analysis of localization patterns of the protein clusters within the platelets
To allow a more objective and quantifiable analysis of the protein localization patterns, the total area of each imaged platelet was obtained from the actin image and divided into five separate concentric zones of equal size (SI Figure S2) . Summing up in which of these zones each of the identified protein cluster in the platelet resided yielded peripheral localization probability profiles, P(r), with   , providing a measure of how centrally/peripherally the protein clusters are located in the platelet, and how activation affects their peripheral distribution. Due to the lower depth resolution, which is the same as in normal confocal microscopy (700-900nm), P(r) is not an absolute value in terms of how peripherally located the proteins are but rather a two dimensional projection of the volume of the platelet (SI figure S3) . On the other hand, since the thickness of the studied platelets is in the order of 1-1.5 µm we will, due to the lower resolution, detect almost all labeled proteins in the platelet.
This effectively decreases the time to scan each individual platelet since there is no need to perform extensive z-stacking of images. The P(r) for the different target protein clusters in control platelets, and in platelets upon ADP-and thrombin-activation are shown in figure 3 (A3,B3,C3 ).
For VEGF a clear reallocation occurs upon ADP stimulation, towards the peripheral parts of the cell where VEGF can be released ( figure 3,A3) . For thrombin-activated and control platelets the distribution of VEGF is more homogenous. PF-4 ( figure 3,B3) mainly resides in the central part of the control platelets but shows a strong reallocation towards the cell membrane upon thrombin activation. Upon ADP activation, PF-4 mainly remains in the central zones but not as clearly as for control cells. Fg ( figure 3, C3) shows an even more central distribution than PF-4 for control cells. Upon thrombin treatment, the proteins move slightly towards the edge, while for ADP there is a significant change, with a majority of the proteins in the two outermost zones. Detailed information regarding the average location, amount and size of the labeled protein intensity profiles is given in table S1 (SI).
Corresponding P(r) profiles were also generated for actin, based on the distribution of the fluorescence intensity between the five zones of the platelets ( figure S4 ). Overall, compared to control platelets, labeled actin is to a larger extent found in the peripheral parts upon ADP-activation, and in the central parts upon thrombin-activation.
However, the P(r) differences are in general smaller than those for the target proteins in figure 3 (A3,B3,C3 ).
Identification of states based on protein cluster size, number of clusters, and the peripheral localization profiles
As a possible strategy to identify different pathophysiological states, we estimated the ability to distinguish the three different states of the platelets (non-, APD-and A3,B3,C3)). The platelets were then assigned to that platelet state, which P(r) by least-squares analysis best resembled that of the platelet. For all targeted proteins and platelet states, this P(r)-assignment always assigned the correct state of the individual platelets with the highest probability (SI, table S2, right column), and apart from thrombin-activated platelets labeled for VEGF (43%), and ADP-activated platelets labeled for PF-4 (42%), with better than 50% probability.
Combining the C D , N c and P(r) assignments above can further improve the identification strength. Here, all platelets assigned to the same state in at least two out of the three separate assignments above, were assigned to that state. The resulting combined assignment probabilities are listed in table 1. For all targeted proteins and platelet states the correct state was assigned with the highest probability. Labeled VEGF can distinguish ADP-activated platelets with 91% probability, and labeled PF-4
and Fg can distinguish thrombin-activated platelets with 73% and 85% probability, respectively. It should be noted that the diagonal elements in the assignment probability matrices in platelets, based on the combined c D , N c , and P(r) assignments of their detected protein clusters. The matrix elements indicate the probability to assign a platelet with a state given by the vertical position in the matrix, to a state indicated by the horisontal position. The three diagonal elements in the matrices (marked gray) thus indicate the probability to correctly assign the different platelet states. Off-diagonal elements indicate miss-classified platelets. Right columns: Fraction of un-classified platelets, for which the three assignment steps resulted in three different assignments. Inspired by recent evidence that platelet dysfunction and alterations in the protein contents in platelets correlate with a range of disease states, including cancer, we investigated if fluorescence nanoscopyof specific proteins in the platelets can be used as a diagnostic procedure, and if spatial mapping of certain proteins, subject to selective storage, release and uptake in the platelets, can reveal features of protein storage and turnover, specific for different physiological or pathophysiological states.
We show that the average size, number, and peripheral localization profiles of regional protein clusters within the platelets can be used to identify three distinct platelet states (non-, ADP-and thrombin-activated), with high specificity at the single platelet level. Moreover, in a diagnostic scenario, given the huge concentration of platelets in peripheral blood, and since STED in contrast to EM can image a sufficient number of platelets in a reasonable time, several platelets from the same individual can be monitored, and the spatial distribution patterns of not only one protein, but of several specific proteins can be analyzed. Thereby, we expect that higher identification strengths can be reached, inherent platelet-to-platelet variations can be taken into consideration, and that a broader range of also less distinct platelet states can be resolved. In summary, the use of high-resolution distribution patterns of specific proteins within platelets as a diagnostic marker opens interesting prospects.
The association of platelet dysfunction with malignancy, and the possibility to detect and characterize aberrant protein storage, release and uptake in platelets with STED microscopy merit further investigations.
Materials and Methods
Platelet isolation
Buffy coat from healthy donors (Blood Central, Karolinska Hospital, Stockholm) was centrifuged (180g, 10 minutes) at room temperature to separate the platelet-containing plasma layer. Dulbecco's modified phosphate buffer saline (DPBS, without Ca 2+ and Mg 2+ , Hyclone) was added to the plasma and the suspension was centrifuged (900g, 10 minutes), resulting in clearly separated layers of red blood cells, platelets and supernatant. The supernatant and platelets were gently aspirated out and resuspended.
In this suspension the cell count of platelets was determined using a hemacytometer and adjusted to 100 ×10 6 /ml with DPBS.
Platelet activation
Platelet suspension (300 μl) was added into a well of a 24-well microplate, where a piece of a polylysine coated coverslip (12 mm) was placed, incubated at 37°C for 1 hour under static condition for cell attachment, and then treated with thrombin (1 NIH unit/ml, Sigma, Sweden) or ADP (10 mM, Sigma, Sweden) for 5 minutes. The cells were then immediately fixed with 3.7% formaldehyde in DPBS for 15 minutes.
Control samples were prepared in parallel without agonist treatment.
Immunostaining
Sheep anti-mouse and goat anti-rabbit antibodies (both from Dianova, Hamburg, Germany) was conjugated with ATTO 594 and ATTO 647N, respectively (Atto-Tec GmbH, Siegen, Germany). Mouse monoclonal antibodies were used for labeling against human PF-4 (R&D Systems, Europe), VEGF (BD Science, Europe), and Fg (Santa Cruz Biotechnology, Heidelberg, Germany). Phalloidin linked with ATTO 647N (Atto-Tec GmbH, Siegen, Germany) was used to stain actin. For colocalization studies rabbit polyclonal antibodies were used for labeling against human PF-4, VEGF, and fibrinogen (all from Santa Cruz Biotechnology, Heidelberg, Germany).
Unless otherwise stated, DPBS was used throughout the study as buffer. The fixed platelets were permeabilized with Triton X-100 (0.2%) for 15 minutes and then blocked for nonspecific binding with bovine serum albumin (1%, Sigma, Sweden) over night at 4°C. The cells were then washed once with DPBS on an orbital shaker (300 rpm), followed by incubation with primary antibodies against PF-4 (2 μg/ml), VEGF (2.5 μg/ml) or Fg (2.5 μg/ml) over night under room temperature. The samples were then washed twice with DPBS on an orbital shaker (300 rpm), incubated with the secondary antibody (3 μg/ml) together with Phalloidin ATTO 647N for 3 hours under room temperature, and then washed three times on an orbital shaker (300 rpm) before being mounted onto microslides with Mowiol-Dabco mounting medium (Sigma, Sweden).
STED microscopy
The home-built STED microscope has been described in detail before [21] , but with a few minor differences [22] . In brief, two excitation beams ( 
Image processing and analysis
Prior to image analysis the STED images were rescaled to 10 nm per pixel and then deconvoluted by 20 iterations of the Richardson-Lucy deconvolution algorithm using a 40 nm Lorentzian PSF [23] . Thereafter, the images were analyzed using a custom written code in Matlab (MathWorks Inc, Massachusetts, USA). In brief, the strategy was to use the protein images (green) to determine the sizes and numbers of their clusters, and the actin images (red) to determine the size and area of platelets. Thereby, combining the green and red images, the total number, density and distribution of the protein clusters within the platelets can be quantified.
The locations of the proteins are determined from the centers of the fluorescent peaks in the images, identified by having an intensity at least four times above the background level within the cell. In order to avoid background effects which may broaden low intensity profiles, the size of the profiles was only calculated for centers where the profile peak intensity was at least ten times higher than the average background level in the cell. The size was calculated for each profile separately as the average FWHM measured over 20 angles. The actin images were used to determine the contact area of the platelets and to create five zones of equal areas within each platelet, surrounding the center of the platelet at different peripheral distances. The distribution of protein clusters between these zones provides a measure of how peripherally localized the proteins are within each platelet.
Statistics
Samples from three different donors were investigated. From each individual blood donor three groups of samples were prepared for studying each of the proteins PF-4, VEGF and Fg, and for each protein, its distribution was monitored for resting platelets, as well as for thrombin-and ADP-treated platelets. From each individual microscopic sample at least eight images were captured on randomly chosen platelets. The number, density, size and distribution of the sub-granule proteins are represented as the 20 average plus and minus the standard deviation of the investigated sets, and taken as the average from the three donors, giving each donor the same impact. Two-tailed student t-tests with unequal variance were applied on the comparisons of interest, and with the results displayed in figure 3 .
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Supplementary information (SI)
Figure S1: Cumulative histograms showing the size (diameter) distribution of the detected regional VEGF (top row), PF-4 (middle row), and Fg (lowest row) protein clusters in inactivated, control platelets (left column), thrombin-activated platelets (middle column), and ADP-activated platelets (rigth column). Number of platelets investigated for each category is indicated in the upper right corner of each histogram, together with the average cluster size (diameter) ± standard deviation. Figure S2 : Determined total area of a platelet, based on the extension of actin (red) fluorescence in the image (left). The middle image shows located peaks (white pixels) for the protein size, number and location analysis. The total area of the platelet was divided into five peripheral zones (right) with equal areas. The five zones were created by finding the center of the platelets actin image and then extending each zone to cover 20% of the total area spanned by the actin (see also methods and materials section).
Figure S3: Each platelet image is a 2-dimensional projection of a three-dimensional volume with a thickness that is the same as the depth (Z) resolution. Due to the lower Z-resolution (700-900nm) as compared to the X-Y resolution (40nm) for the taken STED images, almost the entire volume of the platelet will be projected to the captured two-dimensional image. A protein laying close to the central part of the platelet will also be projected to the central part in the image (B) but a protein located near the top or bottom membrane of the platelet could be depicted to be more centrally located than it actually is (A). Thus p(r) might underestimate the actual distribution of proteins in the platelet but still gives a good estimate as to how peripherally located the proteins are. (C) X-Y images of labeled VEGF and actin show higher resolution for STED as compared to confocal in both dimensions. Corresponding X-Z images of the same platelet (section of the X-Y plane recorded is indicated with a dashed white line) show only higher resolution in the X-dimension. Figure S4 : Peripheral localization profiles, P(r), of actin in inactivated, control (black, dashed), thrombin-activated (blue dashed), and ADP-activated (red dashed) platelets. The P(r) values for actin were calculated based on how the fluorescence from labeled actin was distributed between the five peripheral zones of each platelet. Table S1 : Average values and standard deviations of size, number, density and zone distribution for the three studied proteins and for control (green), thrombin (blue) and ADP (red) treatment. Periph is a value ranging from zero to one where zero means all proteins are in the innermost zone and one means all proteins are in the outermost zone. , N c (second step), and P(r) (third step). The platelet is assigned to a state if two out of the three assignments give the same result. If each assignment step leads to different results, the platelet is "unclassified".
